Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04391595
Title LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Nader Sanai
Indications

high grade glioma

Therapies

Abemaciclib + LY3214996

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST